C-Suite Perspectives

Genomic newborn screening and the BeginNGS project: Q&A with Dr Stephen Kingsmore (Part 2)

kingsmore thumb 2

Rady Children’s Institute for Genomic Medicine (RCIGM) is widely regarded as a key player in the global ecosystem of research groups that are exploring the role of whole genome sequencing for newborn screening. In this Q&A with Will Greene, Healthcare Engagement Lead for Roche Diagnostics Asia Pacific, RCIGM President & CEO Dr Stephen Kingsmore provides […]

Genomic newborn screening and the BeginNGS project: Q&A with Dr Stephen Kingsmore (Part 2) Read More »

Diagnostic whole genome sequencing for rare diseases: Q&A with Dr Stephen Kingsmore (Part 1)

kingsmore part 1 thumb

As President & CEO of Rady Children’s Institute for Genomic Medicine, Dr Stephen Kingsmore plays a key role in driving access to diagnostic whole genome sequencing (WGS) services for children with symptoms of genetic disease. In this Q&A with Will Greene, Healthcare Engagement Lead for Roche Diagnostics Asia Pacific, Dr Kingsmore discusses how the institute provides

Diagnostic whole genome sequencing for rare diseases: Q&A with Dr Stephen Kingsmore (Part 1) Read More »

Redcliffe Labs founder discusses new era of diagnostics in India

Redcliffe Labs founder discusses new era of diagnostics in India_thumbnail

Since its inception in 2018, Redcliffe Labs has endeavoured to be a disrupter in India’s lab diagnostics ecosystem. In this talk at RED 2022, founder and managing director Dheeraj Jain discusses some of the company’s key strategic initiatives, such as the use of temperature controlled transport bags and an AI/ML supported infrastructure with a complete

Redcliffe Labs founder discusses new era of diagnostics in India Read More »

Total lab automation at Shifa International Hospital: Q&A with Dr Imran Nazir Ahmad

Total lab automation at Shifa International Hospital: Q&A with Dr Imran Nazir Ahmad

Widely respected as one of the top quaternary care facilities in Pakistan, Shifa International Hospital recently emerged as the first hospital in Asia Pacific and among the first in the world to pursue total automation of its clinical lab. In this Q&A with Dr Imran Nazir Ahmad, Chief of Pathology and Director of Laboratory at

Total lab automation at Shifa International Hospital: Q&A with Dr Imran Nazir Ahmad Read More »

Dr Phil Reilly on newborn screening: past, present and future

Dr Phil Reilly on newborn screening: past, present and future

Dr Phil Reilly is a physician, clinical geneticist, biotech entrepreneur, venture capitalist and author with deep experience in rare disease diagnostics, including newborn screening (NBS). In this Q&A with Will Greene, Healthcare Engagement Manager and Project Strongbow Co-Lead at Roche Diagnostics Asia Pacific, we learn more about the history and future of NBS technologies in

Dr Phil Reilly on newborn screening: past, present and future Read More »

Hospital management excellence in India: Q&A with Mr Gautam Khanna

Hospital management excellence in India: Q&A with Mr Gautam Khanna

As CEO of P.D. Hinduja Hospital & Medical Research Centre, Gautam Khanna leads one of the premier private hospitals in India. In this Q&A with Narendra Varde, General Manager of Roche Diagnostics India & Neighbouring Markets, we learn more about Khanna’s unique approach to leadership, views on the value of laboratory diagnostics, and hopes for

Hospital management excellence in India: Q&A with Mr Gautam Khanna Read More »

The founding of Ventana Medical Systems: Q&A with Dr Thomas Grogan (Part 1)

The founding of Ventana Medical Systems: Q&A with Dr Thomas Grogan (Part 1)

As the founder of Ventana Medical Systems, a medical technology firm that pioneered the use of automation technologies for tissue diagnostics, Dr Thomas Grogan helped drive many important advances in cancer care In the first instalment of this three-part series on Dr Grogan’s life and career, we hear about the formative experiences that led him

The founding of Ventana Medical Systems: Q&A with Dr Thomas Grogan (Part 1) Read More »

Prof Hans Widjaya on hospital innovation and the future of care (RED 2021)

Prof Hans Widjaya on hospital innovation and the future of care (RED 2021)

As CEO of National Hospital in Surabaya, Prof Hananiel “Hans” Widjaya manages a leading private healthcare facility in Indonesia that has brought many new medical technologies to the country. In this presentation for RED 2021, he shares his hospital’s approach to embracing digital innovation and discusses the key trends that are shaping a new era

Prof Hans Widjaya on hospital innovation and the future of care (RED 2021) Read More »

Scroll to Top